Literature DB >> 19380700

Age-associated leukoaraiosis and cortical cholinergic deafferentation.

N I Bohnen1, M L T M Müller, H Kuwabara, G M Constantine, S A Studenski.   

Abstract

OBJECTIVE: To investigate the relationship between age-associated MRI leukoaraiosis or white matter hyperintensities (WMH) and cortical acetylcholinesterase (AChE) activity.
BACKGROUND: One possible mechanism of cognitive decline in elderly individuals with leukoaraiosis is disruption of cholinergic fibers by strategically located white matter lesions. Periventricular lesions may have a higher chance of disrupting cholinergic projections compared with more superficial nonperiventricular white matter lesions because of anatomic proximity to the major cholinergic axonal projection bundles that originate from the basal forebrain.
METHODS: Community-dwelling, middle-aged and elderly subjects without dementia (mean age 71.0 +/- 9.2 years; 55-84 years; n = 18) underwent brain MRI and AChE PET imaging. The severity of periventricular and nonperiventricular WMH on fluid-attenuated inversion recovery MRI images was scored using the semiquantitative rating scale of Scheltens et al. [11C]methyl-4-piperidinyl propionate AChE PET imaging was used to assess cortical AChE activity. Age-corrected Spearman partial rank correlation coefficients were calculated.
RESULTS: The severity of periventricular (R = -0.52, p = 0.04) but not nonperiventricular (R = -0.20, not significant) WMH was inversely related to global cortical AChE activity. Regional cortical cholinergic effects of periventricular WMH were most significant for the occipital lobe (R = -0.58, p = 0.02).
CONCLUSIONS: The presence of periventricular but not nonperiventricular white matter hyperintensities (WMH) is significantly associated with lower cortical cholinergic activity. These findings support a regionally specific disruption of cholinergic projection fibers by WMH.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19380700      PMCID: PMC2677506          DOI: 10.1212/WNL.0b013e3181a187c6

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  27 in total

1.  Striatal dopamine denervation and sensory integration for balance in middle-aged and older adults.

Authors:  Rakié Cham; Subashan Perera; Stephanie A Studenski; Nicolaas I Bohnen
Journal:  Gait Posture       Date:  2006-12-29       Impact factor: 2.840

2.  Is the whole brain periventricular?

Authors:  F Barkhof; P Scheltens
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-02       Impact factor: 10.154

3.  Serum anticholinergic activity and motor performance in elderly persons.

Authors:  Robert D Nebes; Bruce G Pollock; Edythe M Halligan; Margaret A Kirshner; Patricia R Houck
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2007-01       Impact factor: 6.053

4.  Synthesis of 1-[11C]methylpiperidin-4-yl propionate ([11C]PMP) for in vivo measurements of acetylcholinesterase activity.

Authors:  S E Snyder; L Tluczek; D M Jewett; T B Nguyen; D E Kuhl; M R Kilbourn
Journal:  Nucl Med Biol       Date:  1998-11       Impact factor: 2.408

5.  Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain.

Authors:  N R Selden; D R Gitelman; N Salamon-Murayama; T B Parrish; M M Mesulam
Journal:  Brain       Date:  1998-12       Impact factor: 13.501

6.  Multimodality image registration by maximization of mutual information.

Authors:  F Maes; A Collignon; D Vandermeulen; G Marchal; P Suetens
Journal:  IEEE Trans Med Imaging       Date:  1997-04       Impact factor: 10.048

7.  A new visual rating scale to assess strategic white matter hyperintensities within cholinergic pathways in dementia.

Authors:  Christian Bocti; Richard H Swartz; Fu-Qiang Gao; Demetrios J Sahlas; Pearl Behl; Sandra E Black
Journal:  Stroke       Date:  2005-09-22       Impact factor: 7.914

8.  Kinetic analysis of [(11)C]MP4A using a high-radioactivity brain region that represents an integrated input function for measurement of cerebral acetylcholinesterase activity without arterial blood sampling.

Authors:  S Nagatsuka Si; K Fukushi; H Shinotoh; H Namba; M Iyo; N Tanaka; A Aotsuka; T Ota; S Tanada; T Irie
Journal:  J Cereb Blood Flow Metab       Date:  2001-11       Impact factor: 6.200

9.  Anatomical mapping of white matter hyperintensities (WMH): exploring the relationships between periventricular WMH, deep WMH, and total WMH burden.

Authors:  Charles DeCarli; Evan Fletcher; Vincent Ramey; Danielle Harvey; William J Jagust
Journal:  Stroke       Date:  2004-12-02       Impact factor: 7.914

10.  Neuropsychologic correlates of MRI white matter hyperintensities: a study of 150 normal volunteers.

Authors:  R Schmidt; F Fazekas; H Offenbacher; T Dusek; E Zach; B Reinhart; P Grieshofer; W Freidl; B Eber; M Schumacher
Journal:  Neurology       Date:  1993-12       Impact factor: 9.910

View more
  24 in total

1.  Alterations in cerebral metabolic rate and blood supply across the adult lifespan.

Authors:  Hanzhang Lu; Feng Xu; Karen M Rodrigue; Kristen M Kennedy; Yamei Cheng; Blair Flicker; Andrew C Hebrank; Jinsoo Uh; Denise C Park
Journal:  Cereb Cortex       Date:  2010-11-04       Impact factor: 5.357

2.  Kinetic modeling of [18 F]VAT, a novel radioligand for positron emission tomography imaging vesicular acetylcholine transporter in non-human primate brain.

Authors:  Hongjun Jin; Xuyi Yue; Hui Liu; Junbin Han; Hubert Flores; Yi Su; Stanley M Parsons; Joel S Perlmutter; Zhude Tu
Journal:  J Neurochem       Date:  2018-03-25       Impact factor: 5.372

3.  Feedforward- and motor effort-dependent increase in prefrontal oxygenation during voluntary one-armed cranking.

Authors:  Kei Ishii; Nan Liang; Ryota Asahara; Makoto Takahashi; Kanji Matsukawa
Journal:  J Physiol       Date:  2018-09-30       Impact factor: 5.182

Review 4.  White matter lesions in Parkinson disease.

Authors:  Nicolaas I Bohnen; Roger L Albin
Journal:  Nat Rev Neurol       Date:  2011-02-22       Impact factor: 42.937

5.  Frontal and periventricular brain white matter lesions and cortical deafferentation of cholinergic and other neuromodulatory axonal projections.

Authors:  N I Bohnen; C W Bogan; M L T M Müller
Journal:  Eur Neurol J       Date:  2009-09

6.  Association of Cerebrovascular and Alzheimer Disease Biomarkers With Cholinergic White Matter Degeneration in Cognitively Unimpaired Individuals.

Authors:  Nira Cedres; Daniel Ferreira; Milan Nemy; Alejandra Machado; Joana B Pereira; Sara Shams; Lars-Olof Wahlund; Anna Zettergren; Olga Stepankova; Lenka Vyslouzilova; Maria Eriksdotter; Stefan Teipel; Michel J Grothe; Kaj Blennow; Henrik Zetterberg; Michael Schöll; Silke Kern; Ingmar Skoog; Eric Westman
Journal:  Neurology       Date:  2022-08-02       Impact factor: 11.800

7.  Role of cognitive enhancer therapy in Alzheimer's disease with concomitant cerebral white matter disease: findings from a long-term naturalistic study.

Authors:  Kok Pin Ng; Aloysius Ng; Pryseley Assam; Esther Heng; Nagaendran Kandiah
Journal:  Drugs R D       Date:  2014-09

Review 8.  Early Alzheimer's and Parkinson's disease pathology in urban children: Friend versus Foe responses--it is time to face the evidence.

Authors:  Lilian Calderón-Garcidueñas; Maricela Franco-Lira; Antonieta Mora-Tiscareño; Humberto Medina-Cortina; Ricardo Torres-Jardón; Michael Kavanaugh
Journal:  Biomed Res Int       Date:  2013-02-07       Impact factor: 3.411

9.  Serum and cerebrospinal fluid levels of transthyretin in Lewy body disorders with and without dementia.

Authors:  Walter Maetzler; Youyong Tian; Stephanie Maria Baur; Tina Gauger; Bartholomäus Odoj; Benjamin Schmid; Claudia Schulte; Christian Deuschle; Susanna Heck; Anja Apel; Arthur Melms; Thomas Gasser; Daniela Berg
Journal:  PLoS One       Date:  2012-10-25       Impact factor: 3.240

10.  Contribution of the Cholinergic System to Verbal Memory Performance in Mild Cognitive Impairment.

Authors:  Jessica Peter; Jacob Lahr; Lora Minkova; Eliza Lauer; Michel J Grothe; Stefan Teipel; Lena Köstering; Christoph P Kaller; Bernhard Heimbach; Michael Hüll; Claus Normann; Christoph Nissen; Janine Reis; Stefan Klöppel
Journal:  J Alzheimers Dis       Date:  2016-06-18       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.